RXi Pharmaceuticals Corporation

(RXII) Trade

By |

Profile

RXi Pharmaceuticals Corp is principally engaged in developing therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs.

Contact Information

Website: www.rxipharma.com
Email: tmcgrillen@rxipharma.com
Main Phone: +1 508 767-3861
Address: 257 Simarano Drive
Address 2: Suite 101
State: MA
City / Town: Marlborough
Country: USA
Postal Code: 01752

Issuer Information

Exchange: NSC
CEO: Geert Cauwenbergh
Employees: 15
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 1.88 $ 0.02 (1.08%)
Last Price 1.88 Change $ 0.02 Change % 1.08 Tick N/A
Bid 1.48 Bid Size 100.00 Ask 2.11 Ask Size 1,500.00
Open 1.86 High 1.93 Low 1.79 Prev Close 1.86
Last Trade Volume 81,974 52 Wk Hi 7.70 52 Wk Low 1.78
Market Cap 8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 4,255,566.00 EPS (TTM) -3.88 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 11
Number of Buys 0 7
Number of Sells 0 4
Net Activity 0 -176500
Last 10 Buys Shares
Geert Cauwenbergh 1,000
Geert Cauwenbergh 1,000
Geert Cauwenbergh 1,000
Geert Cauwenbergh 1,000
Geert Cauwenbergh 1,000
Geert Cauwenbergh 1,000
Gerrit Dispersyn 1,000
Geert Cauwenbergh 1,000
Geert Cauwenbergh 1,000
Geert Cauwenbergh 1,000
Last 10 Sell Shares
Alexey Eliseev 1,000
Alexey Eliseev 1,000
Alexey Eliseev 1,000
Alexey Eliseev 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 20 20 20 20
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 20 20 20 20
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/11/18 05/11/18 05/11/18 05/11/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1